Matthew Shea
Stock Analyst at Needham
(1.85)
# 3,190
Out of 5,179 analysts
5
Total ratings
60%
Success rate
1.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TOI The Oncology Institute | Reiterates: Buy | $5 | $2.96 | +68.92% | 3 | Mar 13, 2026 | |
| EVH Evolent Health | Maintains: Buy | $15 → $4 | $2.21 | +81.00% | 1 | Feb 25, 2026 | |
| ASTH Astrana Health | Initiates: Buy | $28 | $24.19 | +15.75% | 1 | Dec 12, 2025 |
The Oncology Institute
Mar 13, 2026
Reiterates: Buy
Price Target: $5
Current: $2.96
Upside: +68.92%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $15 → $4
Current: $2.21
Upside: +81.00%
Astrana Health
Dec 12, 2025
Initiates: Buy
Price Target: $28
Current: $24.19
Upside: +15.75%